Skip to main content
Clinical Trials/CTRI/2020/09/027508
CTRI/2020/09/027508
Not yet recruiting
Phase 2

â??Nidanatmaka study of Medoroga (Adiposopathy) and Upashayatmaka Randomised trial of Nyagrodhadi Ghanavati and Navaka Gugguluâ??

ational Institute of Ayurveda0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Institute of Ayurveda
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Subjects with LDL\-C \>\= 130(mg/dl) at the time of screening.
  • 2\. Subjects with BMI \>\=24
  • 3\. Subjects willing to follow the procedures as per the study protocol and voluntarily give written informed consent.

Exclusion Criteria

  • 1\. Subjects with Diabetes Mellitus Type I and uncontrolled Diabetes Mellitus Type II.
  • 2\. Subjects with uncontrolled Hypothyroidism or Hyperthyroidism
  • 3\. Known cases of Severe/Chronic Hepatic or Renal disease
  • 4\. Known subject of any active malignancy.
  • 5\. Subjects giving history of significant cardiovascular event \< 12 weeks prior to randomization.
  • 6\. Known case of Anorexia Nervosa or Bulimia nervosa
  • 7\. Chronic alcoholics / Alcohol Abuse
  • 8\. Subjects ECG demonstrating any signs of uncontrolled arrhythmia / acute ischemia.
  • 9\. Subjects X\- ray chest showing any active lesion of tuberculosis
  • 10\. Subjects having known chronic, contagious infectious disease, such as active tuberculosis Hepatitis B or C, or HIV.

Outcomes

Primary Outcomes

Not specified

Similar Trials